Leonardo Stella
Rome, 00168, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
Gut Microbiota Biomarkers in Patients with Hepatocellular Carcinoma in the Era of Immune Checkpoint Inhibitors.
Journal: Life (Basel, Switzerland)
Published: February 18, 2026
Long-term outcomes of atezolizumab-bevacizumab in unresectable hepatocellular carcinoma: A real-world study.
Journal: Hepatology (Baltimore, Md.)
Published: November 22, 2025
Establishment of Patient-Derived Organoids from Hepatocellular Carcinoma: Preliminary Data on Yield, Histopathological Concordance, and Methodological Challenges.
Journal: Cells
Published: November 04, 2025
Hepatitis C Eradication Improves Oncologic and Clinical Outcomes in Patients Treated With Atezolizumab Plus Bevacizumab.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: July 23, 2025
Reproducible safety and efficacy of durvalumab with or without tremelimumab for hepatocellular carcinoma in clinical practice: Results of the DT-real study.
Journal: JHEP reports : innovation in hepatology
Published: July 04, 2025
Autobrewery Syndrome and Endogenous Ethanol Production in Patients with MASLD: A Perspective from Chronic Liver Disease.
Journal: International journal of molecular sciences
Published: May 19, 2025
Statins and clinical outcomes in patients with advanced hepatocellular carcinoma treated with Atezolizumab plus Bevacizumab.
Journal: Scientific reports
Published: April 04, 2025
Cancer Vaccines: A Promising Therapeutic Strategy in Advanced Solid Tumors.
Journal: Vaccines
Published: March 15, 2025
Last Updated: 09/26/2026